The University of Chicago Header Logo

Connection

Stephen Hanauer to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Stephen Hanauer has written about Clinical Trials, Phase III as Topic.
Stephen Hanauer
Connection Strength
0.218
Clinical Trials, Phase III as Topic
  1. Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 01; 17(1):139-147.
    View in: PubMed
    Score: 0.158
  2. COLAL-PRED Alizyme. Curr Opin Investig Drugs. 2004 Nov; 5(11):1192-7.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.